CVS vs XGN · P/E 16, rev $402.07B vs rev $55.6M
CVS Health Corp (CVS) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported XGN revenue for 2024-12-31 was $55.6M. Net income was -$15.1M. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. XGN currently screens at market cap $154.1M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. XGN currently screens at market cap $154.1M.
Not investment advice. Open the CVS and XGN stock pages for the full models.
Not investment advice.